Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics

BACKGROUND: The use of tumour xenografts is a well-established research tool in cancer genomics but has not yet been comprehensively evaluated for cancer epigenomics. METHODS: In this study, we assessed the suitability of patient-derived tumour xenografts (PDXs) for methylome analysis using Infinium...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Genome Med
Главные авторы: Guilhamon, Paul, Butcher, Lee M, Presneau, Nadege, Wilson, Gareth A, Feber, Andrew, Paul, Dirk S, Schütte, Moritz, Haybaeck, Johannes, Keilholz, Ulrich, Hoffman, Jens, Ross, Mark T, Flanagan, Adrienne M, Beck, Stephan
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2014
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292812/
https://ncbi.nlm.nih.gov/pubmed/25587359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-014-0116-0
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы